Domains required for assembly of adenovirus type 2 fiber trimers
- PMID: 8794352
- PMCID: PMC190758
- DOI: 10.1128/JVI.70.10.7071-7078.1996
Domains required for assembly of adenovirus type 2 fiber trimers
Abstract
Entry of human adenovirus into cells is a two-step process, mediated in the first step by a specific interaction between the trimeric fiber protein and a specific receptor on the surface of susceptible cells. Because of the interest in human adenovirus as a vector for gene therapy, we have mapped domains in the fiber protein that are important for proper assembly of this trimeric structure and for proper addition of O-linked N-acetylglucosamine (0-GlcNAc). Mutants of adenovirus type 2 fiber in this study were expressed in human cells by use of a recombinant vaccinia virus expression system that yielded protein indistinguishable from the fiber produced during adenovirus infection. The N-terminal half of the protein did not appear to influence fiber trimer formation, since deletions up to 260 amino acids (aa) from the N-terminal end as well as in-frame deletions within the shaft of the molecule still allowed trimerization; internal deletions in the shaft between aa 61 and 260 appeared to alter addition of 0-GlcNAc, as judged by loss of reactivity to a monoclonal antibody specific for this carbohydrate addition. Deletions from the C terminus of the molecule (as small as 2 aa) appeared to prevent trimer formation. Additions of amino acids to the C-terminal end of the fiber showed variable results: a 6-aa addition allowed trimer formation, while a 27-aa addition did not. These trimer-defective mutants were also relatively less stable, as judged kV pulse-chase experiments. Taken together, our results indicate that trimerization of the fiber requires at least two domains, the entire head (aa 400 to 582), and at least the C-terminal-most 15 aa of the shaft.
Similar articles
-
Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber.Virology. 1991 Nov;185(1):365-76. doi: 10.1016/0042-6822(91)90784-9. Virology. 1991. PMID: 1926782
-
Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.J Virol. 1995 May;69(5):2850-7. doi: 10.1128/JVI.69.5.2850-2857.1995. J Virol. 1995. PMID: 7707507 Free PMC article.
-
A Single Maturation Cleavage Site in Adenovirus Impacts Cell Entry and Capsid Assembly.J Virol. 2015 Oct 21;90(1):521-32. doi: 10.1128/JVI.02014-15. Print 2016 Jan 1. J Virol. 2015. PMID: 26491163 Free PMC article.
-
Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins.J Virol. 1990 Nov;64(11):5317-23. doi: 10.1128/JVI.64.11.5317-5323.1990. J Virol. 1990. PMID: 2120471 Free PMC article.
-
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.Virus Res. 2018 Sep 15;257:40-51. doi: 10.1016/j.virusres.2018.08.012. Epub 2018 Aug 17. Virus Res. 2018. PMID: 30125593 Review.
Cited by
-
Recombinantly Expressed Chimeric Fibers Demonstrate Discrete Type-Specific Neutralizing Epitopes in the Fowl Aviadenovirus E (FAdV-E) Fiber, Promoting the Optimization of FAdV Fiber Subunit Vaccines towards Cross-Protection in vivo.Microbiol Spectr. 2022 Feb 23;10(1):e0212321. doi: 10.1128/spectrum.02123-21. Epub 2022 Jan 19. Microbiol Spectr. 2022. PMID: 35044206 Free PMC article.
-
Genetic modification regulates pathogenicity of a fowl adenovirus 4 strain after cell line adaptation (genetic mutation in FAdV-4 lowered pathogenicity).Heliyon. 2023 Sep 9;9(9):e19860. doi: 10.1016/j.heliyon.2023.e19860. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809944 Free PMC article.
-
Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber.J Virol. 1999 Feb;73(2):907-19. doi: 10.1128/JVI.73.2.907-919.1999. J Virol. 1999. PMID: 9882291 Free PMC article.
-
RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection.J Virol. 1999 Jun;73(6):5156-61. doi: 10.1128/JVI.73.6.5156-5161.1999. J Virol. 1999. PMID: 10233980 Free PMC article.
-
In-vivo-targeted gene delivery using adenovirus-antibody site-specific covalent conjugates.Mol Ther Methods Clin Dev. 2025 May 26;33(2):101497. doi: 10.1016/j.omtm.2025.101497. eCollection 2025 Jun 12. Mol Ther Methods Clin Dev. 2025. PMID: 40525123 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources